What changes for tirzepatide prices on 1 January 2027
By the Tirzepatide Price data desk · Article updated 20 Nov 2026 · Prices checked 21 Nov 2026
Offers with an end date of 31 December 2026
Each row is an offer whose own page gives that end date. The last column is what the seller says comes next.
| Offer | Until 31 Dec 2026 | After |
|---|---|---|
| Zepbound savings card, insurance covers the single-dose pen | As little as $25 a fill | Card expires. 2027 terms not published. |
| Zepbound savings card, insurance does not cover it | As low as $499 for the single-dose pen. LillyDirect prices for the KwikPen. | Card expires. 2027 terms not published. |
| Mounjaro savings card | As little as $25 with coverage, as low as $499 without | Card expires. 2027 terms not published. |
| Foundayo 2.5 mg and 5.5 mg at LillyDirect | $149 and $199 a month | Lilly says regular prices will apply. TrumpRx.gov lists them as $199 and $299. |
| Wegovy pen introductory price at NovoCare | $199 for each of the first two fills, new patients | $349 a month, the current regular price |
| Ozempic pen introductory price at NovoCare | $199 for each of the first two fills | Novo Nordisk says pricing will be updated after 31 December 2026. |
| Costco Wegovy 1.5 mg tablets | $149 | $199 |
Read from each seller's page on 20 Nov 2026. Wegovy, Ozempic and Foundayo are not tirzepatide. They are here because they are the prices people compare tirzepatide with. See other GLP-1 prices.
What the savings cards do today
The cards matter most to people with commercial insurance. With coverage for the single-dose pen, the Zepbound card brings a fill to as little as $25. The card takes off up to $100 per month of supply and up to $1,300 per calendar year. Without coverage it sets the single-dose pen at as low as $499 for a 28-day fill. The Mounjaro card works the same way with different caps. Neither card can be used with Medicare, Medicaid or other government coverage (Zepbound terms, Mounjaro terms).
Both sets of terms say the card expires and savings end on 31 December 2026. Lilly also reserves the right to change or end the card at any time. Current figures are on the savings card page.
What has no stated end date
- LillyDirect self-pay Zepbound. The vial and KwikPen prices ($299, $399 and $449 from 7.5 mg with on-time refills) carry no end date on Lilly's page. That is not a promise that they will hold. Lilly has lowered the 2.5 mg vial price 2 times since the vial launched in August 2024. The price history has every step.
- The Medicare GLP-1 Bridge. The $50 copay runs to 31 December 2027 (Medicare.gov). See the Medicare guide.
What we do not know
- Whether Lilly will renew the savings cards for 2027, and on what terms. Nothing is published.
- Whether LillyDirect's self-pay prices will change in January.
- What Novo Nordisk will charge for Ozempic after its page is updated.
- Which state Medicaid agencies will join the CMS BALANCE model. CMS says states can join from May 2026 through 1 January 2027. We have not found a list of states.
How we will track it
We check these pages daily where a script can read them, and we will check the rest by hand in the last week of December. Any change is added to the price history with its date, and this page will be updated with the 2027 terms once the sellers publish them.
Common questions
Will Zepbound cost more in 2027?
Nobody outside Lilly knows yet. The savings card has a published end date and no published replacement. The LillyDirect self-pay prices have no published end date.
Does the $25 Zepbound savings card price end?
The current card expires on 31 December 2026, so the price is confirmed only to that date. Lilly has not said whether a 2027 card will follow.
Does the Medicare $50 copay end on 31 December 2026?
No. The Medicare GLP-1 Bridge runs to 31 December 2027.
Sources
Checked 20 Nov 2026.